Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

Returns on capital

Trinity Biotech plc management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

51.9%

avg 174.1%

ROIC

-15.3%

avg -10.0%

ROA

-35.5%

avg -19.3%

Analysis

ROE is currently the strongest return metric at 51.9% versus its period average of 174.1%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

John Gillard

President, Chief Executive Officer, Company Secretary & DirectorUSD 1.14M4529.17K2.88%

Ronan O'Caoimh

Founder, Director & Executive AdvisorUSD 60K702.92K0.29%

James Walsh

Executive Director of Business Development & Executive DirectorUSD 48K68——

Eibhlin Kelly

Chief Information Officer—41——

Jacqueline O'Neill

Director of Operations—53——

Paul Murphy

Interim Chief Financial Officer——0<0.01%

Jerry Lydon

Head of North America Commercial Operations————

Jordi Romero

Head of Commercial Operations - Europe————

Gary Keating

Chief Technology Officer—53——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 1, 2027.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-11.2%
+35.9% (1yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Recent growth has been strongest in Revenue at -11.2% over three years. Forward estimates point to Revenue at +35.9% (1yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Trinity Biotech plc compete with?

Open similar companies to compare how their management teams allocate capital.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Questions

Management questions

Common questions about TRIB's management, answered from reported figures.

Who manages TRIB?

Trinity Biotech plc (TRIB) lists 9 active executives. The top listed executive is Eibhlin Kelly, Chief Information Officer.

Are TRIB insiders buying or selling?

Recent insider activity shows net selling of $9.14M.